Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides
More topics under "C07K - Peptides" (616,656)
C07K 1 - General processes for the preparation of peptides (51,718)
C07K 11 - Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (895)
C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
C07K 19 - Hybrid peptides (29,428)
C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
Patents for C07K - Peptides (3,738)
05/2013
05/28/2013US8449889 Immuno-molecules containing viral proteins, compositions thereof and methods of using
05/28/2013CA2491946C Ghrelin analogs
05/22/2013CN1732014B Templated native silk smectic gels
05/14/2013US8440201 Stabilized bioactive peptides and methods of identification, synthesis, and use
05/14/2013US8440197 KID3 and KID3 antibodies that bind thereto
05/07/2013US8436148 Antibodies against interleukin-18 binding protein, their preparation and use
04/2013
04/30/2013US8431354 Bacterial pheromones and uses therefor
04/24/2013CN1869061B Peptidomimetic protease inhibitors
04/17/2013EP2581383A1 Skin or hair binding peptides
04/17/2013CN101371923B BAFF receptor (BCMA), an immunoregulatory agent
03/2013
03/27/2013CN101410530B Immuno-amplification
03/27/2013CN101381409B N-terminally chemically modified protein compositions and methods
03/26/2013US8404802 a targeting vector which binds to receptors associated with integrin receptors, angiogenesis; contrast agents; diagnosis of malignant diseases, heart diseases, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma
03/26/2013US8404459 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
03/13/2013CN101633636B Peptidomimetic protease inhibitors
03/12/2013US8394375 Antibodies for amyloid specific peptides
03/12/2013CA2521174C Enhanced hiv-1 vaccines and methods for their use
03/07/2013US20130059337 Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin
03/05/2013US8388971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
02/2013
02/26/2013US8383126 Bacterial pheromones and uses thereof
02/19/2013US8378099 Boronic ester and acid compounds, synthesis and uses
02/14/2013US20130041138 Antibodies that bind to psca proteins for diagnosis of cancer
02/12/2013US8372605 Immuno-amplification
02/12/2013US8372409 Dendritic cell binding proteins and uses thereof
02/05/2013US8367605 Copolymer-1 improvements in compositions of copolymers
01/2013
01/29/2013US8361443 Peptide-based compounds
01/24/2013US20130024956 Antibodies to cd40
01/24/2013US20130023022 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities
01/24/2013US20130023021 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities
01/22/2013CA2536735C Methods for determining cd8+ t-cell epitopes
01/01/2013US8343500 Peptide composition
12/2012
12/27/2012US20120329671 Methods of identifying obm modulators
12/26/2012CN101048425B KID3 and KID3 antibodies that bind thereto
12/25/2012US8338449 Isoquinolinone potassium channel inhibitors
12/20/2012US20120321659 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
12/19/2012CN101301475B Peg化因子vii糖型 Peg factor vii sugar type
11/2012
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/21/2012CN102784385A Peptide selection method
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/07/2012CN102764436A Treatment of TNF alpha related disorders
11/07/2012CN102764425A Peptide selection method
11/01/2012US20120277428 New coupling agents for peptide synthesis
11/01/2012US20120276128 HIV Envelope-CD4 Complexes and Hybrids
10/2012
10/31/2012CN102755646A Medicament for treating TNF alpha related disorder
10/30/2012CA2215161C Proteinase k resistant surface protein of neisseria meningitidis
10/23/2012US8293243 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
10/18/2012US20120264166 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
10/10/2012CN101052414B Immunogenic HBc chimer particles having enhanced stability
10/09/2012US8283444 Non-viral delivery of compounds to mitochondria
10/04/2012US20120252726 Novel neurotrophic factors
10/03/2012CN1846000B HPV CD8+ T-cell epitopes
10/02/2012US8278424 Antibodies that bind to PSCA proteins for diagnosis of cancer
09/2012
09/18/2012US8268965 Template-directed assembly of receptor signaling complexes
09/13/2012US20120230912 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
09/11/2012CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
09/06/2012US20120225014 Antibodies to cd40
09/05/2012CN102653559A Integrin alphaiibbeta3 specific antibodies and peptides
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
08/2012
08/30/2012US20120220517 Glycopegylation Methods and Proteins/Peptides Produced by the Methods
08/30/2012US20120220492 Viral Vectors with Improved Properties
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252907 Methods and compositions for inhibiting binding of IgE to a high affinity receptor
08/23/2012US20120214739 Fgf variants and methods for use thereof
08/21/2012US8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
08/21/2012CA2522812C Hla-a2 tumor associated antigen peptides and compositions
08/16/2012US20120207706 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
08/01/2012EP1585757B1 Peptide deformylase inhibitors
07/2012
07/25/2012EP2479184A2 Beta immunogenic peptide carrier conjugates and methods of producing the same
07/24/2012US8227403 A-β immunogenic peptide carrier conjugates and methods of producing same
07/24/2012US8226955 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
07/19/2012US20120183598 Hla-a2 tumor associated antigen peptides and compositions
07/18/2012CN102584951A Skin or hair binding peptides
07/17/2012US8222211 Preimplantation factor; enhance endometrial receptivity, blocking activated but not basal immunity, inhibiting cell proliferation and creating a TH2 type cytokine bias
07/10/2012US8217169 Coupling agents for peptide synthesis
07/10/2012CA2439101C New medical uses of intercellular communication facilitating compounds
07/04/2012CN102532264A Peptide-based compounds
07/03/2012CA2402593C Monoclonal antibodies to the human ldl receptor, their production and use
06/2012
06/20/2012EP1487479B1 Mutant glycoproteins
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/13/2012EP2463299A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
06/12/2012US8198405 Stabilized alpha helical peptides and uses thereof
06/06/2012EP2460813A1 A beta immunogenic peptide carrier conjugates and methods of producing same
06/06/2012CN1935839B Analogues of GLP-1
05/2012
05/30/2012CN1901930B Integrin alphaiibbeta3 specific antibodies and peptides
05/24/2012US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof
05/23/2012CN101240013B High purity lipopeptides, lipopeptide micelles, processes for preparing same
05/16/2012CN101255431B Corynebacterium glutamicum genes encoding metabolic pathway proteins
05/15/2012CA2516581C Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
05/09/2012EP1660686B1 Hpv cd8+ t-cell epitopes
05/09/2012CN1774232B Skin or hair binding peptides
05/08/2012CA2517291C Ortho-substituted aryl and heteroaryl tie-2 modulators and methods of use
05/08/2012CA2353574C Analogues of glp-1
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012US20120107318 Methods of administering pif agonist peptides and uses thereof
05/01/2012US8168190 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
05/01/2012CA2400559C Humanized antibodies that sequester .alpha..beta. peptide
04/2012
04/26/2012US20120100571 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
04/24/2012US8163697 Selective R-cadherin antagonists and methods
04/18/2012CN1418225B Monoclonal antibodies to the human ldl receptor, their production and use
1 2 3 4 5 6 7 8 9 10 11 12 ... 38